Clinical Nutrition Research Center
Chicago, Illinois, 60616, United States
Location status: Recruiting
Location contact
Amandeep K. Sandhu, PhD.
CONTACT
Indika Edirisinghe, PhD.
CONTACT
NCT Number: NCT06986161
The purpose of this study is to investigate the effect of mango intake on metabolic and inflammatory responses relative to meals in individuals at risk of developing diabetes, as well as to understand how the beneficial compounds found in mangoes are absorbed and processed in the body.
Interested in participating?
Request Info20 year–60 year
All sexes
Interventional
Not applicable
Chicago, Illinois, 60616, United States
Location status: Recruiting
Amandeep K. Sandhu, PhD.
CONTACT
Indika Edirisinghe, PhD.
CONTACT
The primary goal of the proposed project is to advance current knowledge about the antidiabetic and anti-inflammatory benefits of consuming mangoes, especially in individuals with prediabetes, and to determine the best timing of mango intake relative to meals.
Participation in this study will last approximately five weeks and will include six visits: one screening visit lasting about one hour and four study-day visits, each lasting approximately eight hours. During these study visits, blood and urine samples will be collected to help researchers better understand the effects of mango intake relative to meal consumption.
Screening Visit:
Participant eligibility for the study is based on the inclusion and exclusion criteria. To assess this, the participant will need to arrive at the Clinical Nutrition Research Center (CNRC) fasting for 10-12 hours, meaning no food or drink other than plain water during this period.
During the screening visit, the following assessments will be conducted:
Based on the results of the questionnaire, blood glucose levels, physical measurements, and overall health evaluation, the participant may meet the eligibility criteria and be invited to participate in the study. If eligible, they will also be instructed to complete a 24-hour food recall, documenting their food intake over the past day.
PRE-STUDY VISIT: (which may take place on the same day as the screening visit or on a different day)
If the participant qualifies based on their screening results, the Pre-Study visit can take place immediately after their screening or on a later date. This visit lasts approximately 30-45 minutes, during which they will meet with one of our investigators who will provide detailed instructions on the study procedures and how to prepare for each study day. They will also receive training on study procedures, including dietary restrictions, medications and supplements to avoid, food and gastrointestinal assessment (GI-tract diary recording), and overnight fasting requirements. Their study dates will be scheduled, and they will receive a study booklet containing their study calendar and all the instructions covered during the Pre-Study visit.
Procedures for Each Study Day Visit (Visits 1, 2, 3, and 4)
Participants will visit the Clinical Nutrition Research Center (CNRC) on four separate occasions, with a seven-day washout period between each visit. They will consume either the equivalent of one cup of fresh mango (165 grams, ~100 kilocalories) or a calorie-matched control beverage (230 grams, ~100 kilocalories) before, with, or after a meal, as outlined in the study schema.
Confirmation that the participant is prepared for a study day visit: We will collect their three-day food record and verify that they have fasted overnight, consumed a standardized dinner meal, avoided the specified food items, had sufficient sleep, and maintained dietary and exercise patterns consistent with the study procedures. Once everything is confirmed, they will proceed to an exam room, where we will measure their weight, body composition, vital signs (blood pressure, heart rate, and forehead temperature), and check their fasting blood glucose with a finger prick test.
Urine collection: The participant will collect a urine sample using a urine collection cup at the start of the visit (0 hours). Additional samples will be collected at 1 hour, 2 hours, 3 hours, 5 hours, and 7 hours, for a total of six collections throughout the visit.
Blood collection: The Licensed Health Care Provider (LHCP) will collect their blood samples. They can choose between an intravenous catheter or multiple butterfly sticks. A total of seven blood draws will be taken at 0 hours, 0.5 hours, 1 hour, 2 hours, 3 hours, 5 hours, and 7 hours.
Study Beverages and Standardized Breakfast: Once the fasting blood and urine samples are collected, they will receive a pre-meal study beverage. After the 1-hour blood draw, they will be provided with a standardized breakfast meal and a study beverage. Following the 2-hour blood draw, they will receive a post-meal study beverage.
ASA24 Food Recall: The Online Dietary Questionnaire (ASA24) is a web-based questionnaire. We will ask the participant to report everything they ate and drank over the previous day. This questionnaire may take up to 45 minutes to complete each time.
At the End of the Study Day: The participant will be evaluated for safety and any discomfort or symptoms before leaving. They will receive a take-home snack, and compensation will be issued after all study procedures are completed. Additionally, they will be given instructions on how to prepare for their next visit.
How much blood will be collected during the study visit?: During each of the four study visits, blood will be collected a total of seven times per visit, with a total of 280 milliliters of blood collected throughout the study across all visits.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Mango beverage
Italian Ice beverage
Time frame: 7 hours
Change in postprandial glucose as measured by absolute values and calculated insulin sensitivity using homeostasis model assessment of fasting insulin sensitivity (HOMA-%S) and B-cell function (HOMA-%).
Time frame: 7 hours
Change in postprandial glucose as measured by assessment of peripheral insulin sensitivity using Matsuda index.
Time frame: 7 hours
Change in postprandial insulin as measured by absolute values and calculated insulin sensitivity using homeostasis model assessment of fasting insulin sensitivity (HOMA-%S) and B-cell function (HOMA-%).
Time frame: 7 hours
Change in postprandial insulin as measured by assessment of peripheral insulin sensitivity using Matsuda index.
Time frame: 7 hours
Assessments to address this aim will include analysis of systemic markers of inflammation (IL-6) in plasma using ELISA method
Time frame: 7 hours
Assessments to address this aim will include analysis of systemic markers of inflammation (TNF-α) in plasma using ELISA method
Time frame: 7 hours
Polyphenolic metabolites (phenolic acids and derivatives components) will be identified and quantified in urine and plasma. Metabolites in samples will be identified and quantified using an Agilent 6550 iFunnel ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UHPLC/Q-TOF-MS) and 6460 ultra-high performance liquid chromatography- triple quadrupole mass spectrometry (UHPLC-QQQ-MS), respectively
Contact information is provided by the study sponsor or research team.
Amandeep K. Sandhu, PhD.
CONTACT
Chelsea Preiss, M.S.
CONTACT
Clinical Nutrition Research Center, Illinois Institute of Technology
Industry
Optimizing Mango's Glycemic Impact: Investigating Mango Consumption Timing in Relation to Meal in Prediabetic Individuals
Acronym: MG3
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07713030
Behavior, Diabetes Mellitus
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT07118098
Autoimmune Diseases, Diabetes Mellitus
Vienna, Austria
View Trial DetailsNCT06426277
Diabetes Mellitus, Endocrine System Diseases
Goiânia, Goiás, Brazil
View Trial DetailsNCT07111026
Behavior, Behavioral Symptoms
Ellenton, Georgia, United States
View Trial Details